FDA coordinates with pharma to address IV fluid shortage

The FDA's Center for Veterinary Medicine announced on April 13 that it has a plan in place to address a shortage of IV fluids used to treat large animals. The shortage of 3-litre and 5-litre doses has been caused by a combination of increased demand and decreased production, according to a statement from the FDA. Manufacturers have responded by shifting production to smaller sizes, which can be used for treating people and pets but not larger animals. The agency plans to work with several pharma companies that are preparing to import IV fluids from foreign countries to help ease the shortage, the agency says. Release

Suggested Articles

The United Nations’ 2030 Agenda for Sustainable Development lays out a host of priorities including “food security and nutrition,” an ambitious plan to…

Starting next year, drugmakers that market antibiotics for food animals will face tough new FDA rules limiting their use. So now some pharma companies are…

The USDA plans to hold manufacturers of veterinary biotech drugs to new, strict standards on labeling. Although companies will have between four and six years…